| Leuprolide studied in …STUDIED_INderived186 of 186show fewer |
|---|
| → studied in | NCT05827081Phase 3 · recruiting Phase IIIb Study of Ribociclib + ET in Early Breast Cancer · 186 trials list this drug (42 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07650240Phase 2 · recruiting Study of PSMA-targeted Therapy and Androgen Receptor Suppression in Low-volume Metastatic ProstatE Cancer: SPARKLE Trial · 186 trials list this drug (42 active) | — | — | Prostate Adenocarcinoma,Malignant Prostate Neoplasm,Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03070886Phase 2/Phase 3 · active not recruiting Antiandrogen Therapy and Radiation Therapy With or Without Docetaxel in Treating Patients With Prostate Cancer That Has Been Removed by Surgery · 186 trials list this drug (42 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02960022Phase 2 · active not recruiting A Study for Subjects With Prostate Cancer Who Previously Participated in an Enzalutamide Clinical Study · 186 trials list this drug (42 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06654336Phase 2 · recruiting Study of Recurrence-directed Therapy (RDT) With or Without Androgen-Deprivation Therapy (ADT) In Patients With Radio-recurrent Oligo-metastatic Hormone/Castrate Sensitive Prostate Cancer (romCSPC) · 186 trials list this drug (42 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04423211Phase 3 · recruiting Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging · 186 trials list this drug (42 active) | — | — | Prostate Adenocarcinoma,Malignant Prostate Neoplasm,Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04513717Phase 3 · active not recruiting Two Studies for Patients With High Risk Prostate Cancer Testing Less Intense Treatment for Patients With a Low Gene Risk Score and Testing a More Intense Treatment for Patients With a High Gene Risk Score, The PREDICT-RT Trial · 186 trials list this drug (42 active) | — | — | Prostate Adenocarcinoma,Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05050084Phase 3 · active not recruiting Two Studies for Patients With Unfavorable Intermediate Risk Prostate Cancer Testing Less Intense Treatment for Patients With a Low Gene Risk Score and Testing a More Intense Treatment for Patients With a Higher Gene Risk Score, The Guidance Trial · 186 trials list this drug (42 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01786265Phase 2 · active not recruiting Finite Androgen Ablation With or Without Abiraterone Acetate and Prednisone in Treating Patients With Recurrent Prostate Cancer · 186 trials list this drug (42 active) | — | — | Prostate Adenocarcinoma,Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06305598Phase 1 · active not recruiting Bipolar Androgen Therapy to Restore Sensitivity to Androgen Deprivation Therapy for Patients With Metastatic Castration Resistant Prostate Cancer · 186 trials list this drug (42 active) | — | — | Malignant Prostate Neoplasm,Prostate Carcinoma,Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07455903Phase 2 · recruiting Assessing Efficacy of Neoadjuvant ADT in Localized High-Risk Prostate Cancer Patients Utilizing 18F-Flotufolastat PSMA PET/CT · 186 trials list this drug (42 active) | — | — | Malignant Prostate Neoplasm,Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05669664Phase 2 · active not recruiting Testing the Anti-cancer Drug Darolutamide in Patients With Testosterone-Driven Salivary Gland Cancers · 186 trials list this drug (42 active) | — | — | Salivary Gland Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05765500Phase 2 · recruiting RecoverPC: Relugolix vs GnRH Agonist in Quality of Life · 186 trials list this drug (42 active) | — | — | Prostate Neoplasm,Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04484818Phase 3 · active not recruiting Testing the Addition of Darolutamide to Hormonal Therapy (Androgen Deprivation Therapy [ADT]) After Surgery for Men With High-Risk Prostate Cancer, The ERADICATE Study · 186 trials list this drug (42 active) | — | — | Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06169124Phase 2 · active not recruiting Study to Test the Drug Darolutamide Along With the Drugs Leuprolide Acetate and Exemestane in Patients With Recurrent Ovarian Granulosa Cell Tumors · 186 trials list this drug (42 active) | — | — | Adult Ovarian Granulosa Cell Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06378866Phase 2 · recruiting Stereotactic Body Radiation Therapy Plus Immediate or Delayed Androgen Receptor Pathway Inhibitor and Androgen Deprivation Therapy or Salvage Radiation Therapy for the Treatment of Prostate Cancer, DIVINE Trial · 186 trials list this drug (42 active) | — | — | Malignant Prostate Neoplasm,Castration-Resistant Prostate Carcinoma,Castration-Sensitive Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02346253NA · completed High-Dose Brachytherapy in Treating Patients With Prostate Cancer · 186 trials list this drug (42 active) | — | — | Prostate Adenocarcinoma,Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07158021Phase 2 · recruiting Leuprolide and Goserelin for Ovarian Function Suppression in Pre- or Peri-menopausal Women With Breast Cancer, OFS Trial · 186 trials list this drug (42 active) | — | — | Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07027124Phase 2 · recruiting Neoadjuvant ADT + Darolutamide With Pembrolizumab, Followed by Adjuvant Pembrolizumab in Molecularly Stratified High-Risk Prostate Cancer · 186 trials list this drug (42 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05605964Phase 3 · completed Randomized Study to Evaluate MACE in Patients With Prostate Cancer Treated With Relugolix or Leuprolide Acetate · 186 trials list this drug (42 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00544830Phase 2 · active not recruiting Hormone Therapy and Intensity-Modulated Radiation Therapy in Treating Patients With Metastatic Prostate Cancer · 186 trials list this drug (42 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04194554Phase 1/Phase 2 · active not recruiting A Multi-Center Trial of Androgen Suppression With Abiraterone Acetate, Leuprolide, PARP Inhibition and Stereotactic Body Radiotherapy in Prostate Cancer · 186 trials list this drug (42 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02772588Phase 2 · completed AASUR in High Risk Prostate Cancer · 186 trials list this drug (42 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03361735Phase 2 · active not recruiting Radium Ra 223 Dichloride, Hormone Therapy and Stereotactic Body Radiation Therapy in Treating Patients With Metastatic Prostate Cancer · 186 trials list this drug (42 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06330805Phase 2 · recruiting Effects of Relugolix vs Leuprolide on Cardiac Function in Patients With Prostate Cancer · 186 trials list this drug (42 active) | — | — | Prostate Adenocarcinoma,Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06650579Phase 3 · recruiting REVELUTION-2: Relugolix+Abiraterone Acetate (AA) Versus Leuprolide+AA Cardiac Trial · 186 trials list this drug (42 active) | — | — | Malignant Prostate Neoplasm,Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02274779Phase 2 · completed Salvage Radiotherapy Combined With Hormonotherapy in Oligometastatic Pelvic Node Relapses of Prostate Cancer · 186 trials list this drug (42 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05320406Phase 2 · active not recruiting RElugolix VErsus LeUprolide Cardiac Trial · 186 trials list this drug (42 active) | — | — | Malignant Prostate Neoplasm,Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06627530Phase 4 · active not recruiting COACTION Trial - COmbination Androgen bloCkade in inTermediate to hIgh-risk prOstate caNcer · 186 trials list this drug (42 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01674140Phase 3 · active not recruiting S1207 Hormone Therapy With or Without Everolimus in Treating Patients With Breast Cancer · 186 trials list this drug (42 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03902951Phase 2 · active not recruiting Antiandrogen Therapy and SBRT in Treating Patients With Recurrent, Metastatic Prostate Cancer · 186 trials list this drug (42 active) | — | — | Prostate Adenocarcinoma,Malignant Prostate Neoplasm,Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04455750Phase 3 · active not recruiting A Clinical Study Evaluating The Benefit of Adding Rucaparib to Enzalutamide for Men With Metastatic Prostate Cancer That Has Become Resistant To Testosterone-Deprivation Therapy · 186 trials list this drug (42 active) | — | — | Prostate Adenocarcinoma,Malignant Prostate Neoplasm,Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05701007completed Real World Evidence Study on Metastatic Prostate Cancer in the Pirkanmaa Hospital District in Finland · 186 trials list this drug (42 active) | — | — | Castration-Resistant Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04734730Phase 2 · recruiting Talazoparib With Androgen Deprivation Therapy and Abiraterone for the Treatment of Castration Sensitive Prostate Cancer · 186 trials list this drug (42 active) | — | — | Prostate Adenocarcinoma,Malignant Prostate Neoplasm,Castration-Sensitive Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03056755Phase 2 · completed Study Assessing the Efficacy and Safety of Alpelisib Plus Fulvestrant or Letrozole, Based on Prior Endocrine Therapy, in Patients With PIK3CA Mutant, HR+, HER2- Advanced Breast Cancer Who Have Progressed on or After Prior Treatments · 186 trials list this drug (42 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01746849Phase 2 · active not recruiting Palifermin With Leuprolide Acetate for the Promotion of Immune Recovery Following Total Body Irradiation Based T-Cell Depleted Allogeneic Hematopoietic Stem Cell Transplantation · 186 trials list this drug (42 active) | — | — | Leukemia,Multiple Myeloma,Myelodysplastic Syndrome+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03007732Phase 2 · completed Pembrolizumab +/- SD-101 in Hormone-Naïve Oligometastatic Prostate Cancer With RT and iADT · 186 trials list this drug (42 active) | — | — | Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07159451Phase 2 · recruiting A Short-term Preoperative, Evaluating Activity and Safety of Elacestrant Monotherapy as Compared to Elacestrant + Ovarian Function Suppression (LHRH Agonist) in Premenopausal Patients With Stage I-II ER+/HER2- Breast Cancer · 186 trials list this drug (42 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02023463Phase 1 · active not recruiting Enzalutamide, Radiation Therapy and Hormone Therapy in Treating Patients With Intermediate or High-Risk Prostate Cancer · 186 trials list this drug (42 active) | — | — | Prostate Adenocarcinoma,Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06348264Phase 2 · recruiting Adjuvant Rezvilutamide in Combination With Androgen Deprivation Therapy in Androgen Receptor-positive, High-risk Salivary Duct Carcinoma · 186 trials list this drug (42 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03678025Phase 3 · recruiting Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer · 186 trials list this drug (42 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03298087Phase 2 · completed Systemic and Tumor-Directed Therapy for Oligometastatic Prostate Cancer · 186 trials list this drug (42 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04249154Phase 2 · recruiting Postop Hypofractionated Radiation Therapy and LHRH in Patients With Prostate Cancer · 186 trials list this drug (42 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02903368Phase 2 · completed Neoadjuvant And Adjuvant Abiraterone Acetate + Apalutamide Prostate Cancer Undergoing Prostatectomy · 186 trials list this drug (42 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02278185Phase 2 · completed Enzalutamide Versus Standard Androgen Deprivation Therapy for the Treatment Hormone Sensitive Prostate Cancer · 186 trials list this drug (42 active) | — | — | Prostate Adenocarcinoma,Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03951831Phase 2 · active not recruiting REGN2810 Followed by Chemoimmunotherapy for Newly Metastatic Hormone-sensitive Prostate Cancer · 186 trials list this drug (42 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04302454Phase 3 · active not recruiting Androgen Deprivation Therapy for Oligo-recurrent Prostate Cancer in Addition to radioTherapy · 186 trials list this drug (42 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05169112Phase 3 · recruiting Impact of Hormonal Therapy on Prostate Cancer Recurrence After Radical Prostatectomy · 186 trials list this drug (42 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05440383Phase 3 · completed A Clinical Study of KLH-2109 in Uterine Fibroids Patient With Menorrhagia · 186 trials list this drug (42 active) | — | — | Uterine Corpus Leiomyoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02685397Phase 2/Phase 3 · active not recruiting Management of Castration-Resistant Prostate Cancer with Oligometastases · 186 trials list this drug (42 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03035032Phase 4 · completed A Study of ELIGARD® in Hormone-dependent Prostate Cancer Patients · 186 trials list this drug (42 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02366494completed Micro RNAs to Predict Response to Androgen Deprivation Therapy · 186 trials list this drug (42 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03990194withdrawn Real-life Study of Patients After 3-months of Leuprorelin 5mg Implant in Prostate Cancer · 186 trials list this drug (42 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01442246Phase 3 · active not recruiting Evaluation of Adjuvant Hormonal Treatment for 24 Months After Radical Prostatectomy in High Risk of Recurrence Patients. · 186 trials list this drug (42 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03900637Phase 2 · active not recruiting PersonaLized neoAdjuvant Strategy ER Positive and HER2 Negative Breast Cancer TO Increase BCS Rate · 186 trials list this drug (42 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01194271Phase 2 · completed Neoadjuvant Ipilimumab in Prostate Cancer · 186 trials list this drug (42 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02344472Phase 3 · unknown Detect V / CHEVENDO (Chemo vs. Endo) · 186 trials list this drug (42 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03572387Phase 2 · completed A Pilot Study of 5-AZA and ATRA for Prostate Cancer With PSA-only Recurrence After Local Treatment · 186 trials list this drug (42 active) | — | — | Prostate Neoplasm,Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03272477Phase 2 · completed Study to Compare Neoadjuvant Combination of Trastuzumab and Pertuzumab With Concurrent Taxane Chemotherapy or Endocrine Therapy and Quality of Life Assessment Under Adjuvant Therapy in Operable HER2+/HR+ Breast Cancer Patients · 186 trials list this drug (42 active) | — | — | Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02543255Phase 2 · completed Anti-Androgens and Cabazitaxel in Defining Complete Response in Prostatectomy (ACDC Trial) · 186 trials list this drug (42 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00541047Phase 3 · completed RADICALS - Radiotherapy and Androgen Deprivation In Combination After Local Surgery · 186 trials list this drug (42 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02941926Phase 3 · completed Study to Assess the Safety and Efficacy of Ribociclib (LEE011) in Combination With Letrozole for the Treatment of Men and Pre/Postmenopausal Women With HR+ HER2- aBC · 186 trials list this drug (42 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01377389Phase 2 · terminated Ipilimumab + Androgen Depravation Therapy in Prostate Cancer · 186 trials list this drug (42 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00002889Phase 2 · completed Radiation Therapy With Androgen Suppression in Treating Patients With Prostate Cancer · 186 trials list this drug (42 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00651326Phase 3 · terminated Androgen Suppression and Radiation With/Out Docetaxel in High-Risk Localized Prostate Cancer · 186 trials list this drug (42 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04914195Phase 3 · completed Leuprolide Acetate 3.75 mg Depot Injection for Patients With Advanced Prostate Cancer · 186 trials list this drug (42 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04897958completed Prediction of the PRONOUNCE Prostate Cancer Trial in Healthcare Claims Data · 186 trials list this drug (42 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01326312Phase 2 · terminated Effect of GTx-758 on Total and Free Testosterone Levels in Men With Prostate Cancer · 186 trials list this drug (42 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00771017Phase 2 · withdrawn Androgen Ablation Therapy With or Without Vaccine Therapy in Treating Patients With Prostate Cancer · 186 trials list this drug (42 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02058706Phase 2 · completed LHRH Analogue Therapy With Enzalutamide or Bicalutamide in Treating Patients With Hormone Sensitive Prostate Cancer · 186 trials list this drug (42 active) | — | — | Prostate Adenocarcinoma,Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03043807Phase 2 · completed A Study of Definitive Therapy to Treat Prostate Cancer After Prostatectomy · 186 trials list this drug (42 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02914158Phase 3 · unknown Adjuvant Ovarian Suppression Plus Aromatase Inhibitor or Tamoxifen in Young Women · 186 trials list this drug (42 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02064036Phase 1 · completed Stereotactic Boost and Long-Term Androgen Deprivation for Adenocarcinoma of the Prostate · 186 trials list this drug (42 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01989780Phase 2 · completed Bevacizumab Plus Paclitaxel Optimization Study With Interventional Aintenance Endocrine Therapy in Breast Cancer · 186 trials list this drug (42 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02716974Phase 2 · completed A Study of Definitive Therapy to Treat Prostate Cancer · 186 trials list this drug (42 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02663908Phase 3 · terminated A Trial Comparing Cardiovascular Safety of Degarelix Versus Leuprolide in Patients With Advanced Prostate Cancer and Cardiovascular Disease · 186 trials list this drug (42 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02770391Phase 2 · completed Apalutamide and Leuprolide in Intermediate and High-risk Prostate Cancer · 186 trials list this drug (42 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04331717Phase 2 · withdrawn Bariatric Arterial Embolization for Men Starting Hormones for Prostate Cancer · 186 trials list this drug (42 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02268175Phase 2 · completed Enzalutamide/Leuprolide +/- Abiraterone/Pred in Prostate · 186 trials list this drug (42 active) | — | — | Prostate Adenocarcinoma,Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05304169Phase 4 · completed Study to Evaluate the Safety and Efficacy of Switching From Zoladex® Monthly or Quarterly, to Eligard® Semiannual. · 186 trials list this drug (42 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05212857Phase 2 · unknown Enhanced Systemic Combined With Local Treatment for Primary and Metastatic Lesions in Oligo-metastatic Prostate Cancer · 186 trials list this drug (42 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03085095Phase 3 · completed A Study to Evaluate the Safety and Efficacy of Relugolix in Men With Advanced Prostate Cancer · 186 trials list this drug (42 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05087706unknown Exploratory Study of Molecular Profile-Associated Evidence Guided Precision Therapy for Salivary Gland Cancer（MAPS） · 186 trials list this drug (42 active) | — | — | Salivary Gland Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02508636Phase 2 · terminated Trial of Radiotherapy With Leuprolide and Enzalutamide in High Risk Prostate Cancer · 186 trials list this drug (42 active) | — | — | Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04248621Phase 4 · unknown Androgen Deprivation Therapy on Bone Mineral Density Change in Prostate Cancer Patients · 186 trials list this drug (42 active) | — | — | Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00003653Phase 3 · completed Hormone Therapy in Treating Patients With Rising PSA Levels Following Radiation Therapy for Prostate Cancer · 186 trials list this drug (42 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03541928Phase 2 · recruiting Phase II High Risk Prostate Cancer Trial Using Gene & Androgen Deprivation Therapies, Radiotherapy, & Surgery · 186 trials list this drug (42 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01338987Phase 2 · completed Pilot Study of Leuprolide to Improve Immune Function After Allogeneic Bone Marrow Transplantation · 186 trials list this drug (42 active) | — | — | Acute Lymphoblastic Leukemia,Myelodysplastic Syndrome,Myeloid Leukemia+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04783636Phase 1 · unknown To Compare the Safety and Pharmacokinetics of PT105 With PT105R in Healthy Postmenopausal Female Volunteers · 186 trials list this drug (42 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04585932Phase 2 · withdrawn Androgen Deprivation Therapy and Apalutamide With or Without Radiation Therapy for the Treatment of Biochemically Recurrent Prostate Cancer, RESTART Study · 186 trials list this drug (42 active) | — | — | Malignant Prostate Neoplasm,Oligometastatic Prostate Carcinoma,Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02064582Phase 2 · completed Enzalutamide and Hormone Therapy Before, During, and After Radiation for High Risk Localized Prostate Cancer · 186 trials list this drug (42 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02059213Phase 2 · completed A Phase II Study of Androgen Deprivation Therapy With or Without Palbociclib in RB-Positive Metastatic Prostate Cancer · 186 trials list this drug (42 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02344550Phase 2 · completed Study of GnRH-A [Leuprorelin(Lorelin Depot] Plus Leterozole +/- Everolimus for Premenopausal Women With Metastatic Breast Cancer · 186 trials list this drug (42 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02168062Phase 2 · terminated Supportive Therapy in Androgen Deprivation Clinic in Improving Health Outcomes and Managing Side Effects in Patients With Prostate Cancer · 186 trials list this drug (42 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02742675Phase 2 · unknown Androgen Deprivation Therapy or Androgen Deprivation Therapy Plus Definitive Treatment (Radiation or Surgery) · 186 trials list this drug (42 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03261999Phase 3 · completed Safety, Efficacy, and Pharmacokinetic Behavior of Leuprolide Mesylate (LMIS 25 mg) in Subjects With Prostate Cancer · 186 trials list this drug (42 active) | — | — | Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00003645Phase 3 · terminated Randomized Trial of Adjuvant Hormonal Therapy in Surgically Treated Prostate Cancer Patients at High Risk for Recurrence · 186 trials list this drug (42 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03093272Phase 2 · terminated A Study of Docetaxel + ARN-509 in Castration-Resistant Prostate Cancer · 186 trials list this drug (42 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00002633Phase 3 · completed Hormone Therapy With or Without Surgery or Radiation Therapy in Treating Patients With Prostate Cancer · 186 trials list this drug (42 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04094467Phase 4 · unknown Comparison Between Two Different Protocols in Polycystic Ovary Symdrome Women Undergoing Intra-cytoplasmic Injection · 186 trials list this drug (42 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00937768Phase 2 · terminated Leuprolide Acetate or Goserelin Acetate Compared With Observation in Treating Patients With High-Risk Prostate Cancer Who Have Undergone Radical Prostatectomy · 186 trials list this drug (42 active) | — | — | Prostate Adenocarcinoma,Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03209518completed Special Drug Use Surveillance of Leuprorelin for Injection Kit 22.5 mg in "Premenopausal Breast Cancer" · 186 trials list this drug (42 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00254397Phase 2 · completed Melanoma Vaccine With Peptides and Leuprolide · 186 trials list this drug (42 active) | — | — | Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02085252Phase 3 · completed A Study of the Effect of Enantone LP 11.25 mg (Leuprorelin) on the Histological Progression of Indolent Prostate Cancer · 186 trials list this drug (42 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03209492completed Special Drug Use Surveillance of Leuplin PRO for Injection Kit 22.5 mg for "Prostate Cancer" · 186 trials list this drug (42 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02592746Phase 2 · unknown A Study of Palbociclib With Exemestane Plus GnRH Versus Capecitabine in Premenopausal Women With HR+ MBC · 186 trials list this drug (42 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02655237Phase 3 · completed A Phase 3 Study to Evaluate the Efficacy and Safety of Relugolix (TAK-385) 40 mg Compared With Leuprorelin in the Treatment of Uterine Fibroids · 186 trials list this drug (42 active) | — | — | Uterine Corpus Leiomyoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02234115Phase 3 · completed Safety, Efficacy, and Pharmacokinetic Behavior of Leuprolide Mesylate in Subjects With Advanced Prostate Carcinoma · 186 trials list this drug (42 active) | — | — | Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01163084Phase 1/Phase 2 · terminated Leuprolide Acetate or Goserelin Acetate With or Without Vismodegib Followed by Surgery in Treating Patients With Locally Advanced Prostate Cancer · 186 trials list this drug (42 active) | — | — | Prostate Adenocarcinoma,Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01136226Phase 4 · completed Evaluate Recovery of Testosterone for Patients Using Eligard · 186 trials list this drug (42 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01547299Phase 2 · completed Study of Enzalutamide (Formerly MDV3100) as a Neoadjuvant Therapy for Patients Undergoing Prostatectomy for Localized Prostate Cancer · 186 trials list this drug (42 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02689921Phase 2 · unknown NEOADjuvant Aromatase Inhibitor and Pertuzumab/Trastuzumab for Women With Breast Cancer · 186 trials list this drug (42 active) | — | — | Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00223665Phase 2 · completed Effects of IAS in Men With Localized Biochemical Relapsed Prostate Cancer · 186 trials list this drug (42 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01422096early Phase 1 · withdrawn Effect of Short Term Ovarian Suppression on Androgen Overproduction in Overweight Girls With Androgen Excess · 186 trials list this drug (42 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00002597Phase 3 · completed Radiation Therapy With or Without Antiandrogen Therapy in Treating Patients With Stage I or Stage II Prostate Cancer · 186 trials list this drug (42 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00004635Phase 3 · completed Thalidomide for the Treatment of Hormone-Dependent Prostate Cancer · 186 trials list this drug (42 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02083185Phase 2 · completed A Phase 2 Study to Evaluate the Safety and Efficacy of TAK-385, Together With a Leuprorelin Observational Cohort, in Participants With Prostate Cancer · 186 trials list this drug (42 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03497702Phase 2 · unknown Neo-adjuvant Chemotherapy With Letrozole in Patients With Estrogen Receptor Positive/HER-2 Negative Breast Cancer · 186 trials list this drug (42 active) | — | — | Malignant Breast Neoplasm,Invasive Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00860158Phase 2 · terminated Neoadjuvant Dasatinib Plus LHRH Analogue Therapy in High-Risk Localized Prostate Cancer · 186 trials list this drug (42 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01120236Phase 2 · completed Bicalutamide and Goserelin or Leuprolide Acetate With or Without Cixutumumab in Treating Patients With Newly Diagnosed Metastatic Prostate Cancer · 186 trials list this drug (42 active) | — | — | Prostate Adenocarcinoma,Malignant Prostate Neoplasm,Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02736435Phase 3 · withdrawn Treatment of Uterine Fibroids With Magnetic Resonance Guided High Intensity Focused Ultrasound · 186 trials list this drug (42 active) | — | — | Uterine Corpus Leiomyoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01343368Phase 2 · terminated Preservation of Ovarian Function After Hematopoietic Cell Transplant · 186 trials list this drug (42 active) | — | — | Hodgkin Lymphoma,Multiple Myeloma,Myeloproliferative Neoplasm+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00193856Phase 3 · completed RADAR Trial - Randomised Androgen Deprivation and Radiotherapy · 186 trials list this drug (42 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00589472Phase 2 · completed Androgen Deprivation Therapy and Vorinostat Followed by Radical Prostatectomy in Treating Patients With Localized Prostate Cancer · 186 trials list this drug (42 active) | — | — | Prostate Adenocarcinoma,Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01023061Phase 2 · completed Abiraterone Prednisone and Hormonal Therapy Before and During Radiation Therapy in Localized Prostate Cancer · 186 trials list this drug (42 active) | — | — | Prostate Adenocarcinoma,Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00225420Phase 1/Phase 2 · completed Docetaxel, Androgen Ablation, and External-Beam Radiation Therapy in Patients With High-Risk Localized Prostate Cancer · 186 trials list this drug (42 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01431391Phase 2 · completed Sequencing of Sipuleucel-T and ADT in Men With Non-metastatic Prostate Cancer · 186 trials list this drug (42 active) | — | — | Prostate Neoplasm,Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02107391Phase 2 · completed Phase II Study of DCVAC/PCa Added to Hormone Therapy for Men With Metastatic Prostate Cancer · 186 trials list this drug (42 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00170157Phase 2 · completed Hormone Therapy and Ipilimumab in Treating Patients With Advanced Prostate Cancer · 186 trials list this drug (42 active) | — | — | Prostate Adenocarcinoma,Malignant Prostate Neoplasm,Prostate Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02212197Phase 2 · completed Phase II Study of Subcutaneous Injection Depot of Leuprolide Acetate in Patient With Prostate Cancer · 186 trials list this drug (42 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00380406Phase 3 · completed PROtecting Ovaries and Fertility During Chemotherapy - The PROOF Trial · 186 trials list this drug (42 active) | — | — | Malignant Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02167893completed Leuplin SR 11.25 mg Injection Kit Specified Drug-use Survey "Long-term Use Survey in Prostate Cancer Patients (96 Weeks)" · 186 trials list this drug (42 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01933022Phase 4 · terminated A Study in Patients With Metastatic Prostate Cancer to Assess How the Drug Eligard®, Affects Certain Markers in Blood and Urine, Which Are Indicators for the Disease · 186 trials list this drug (42 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03029533Phase 1 · unknown Phase 1 Study to Evaluate the Pharmacokinetics and Safety Following SC Administration of DWJ108J in Patients With Prostate Cancer · 186 trials list this drug (42 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00928434Phase 3 · completed A Study of Degarelix in Patients With Prostate Cancer · 186 trials list this drug (42 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01750398Phase 2 · completed Bipolar Androgen-based Therapy for Prostate Cancer (BAT) · 186 trials list this drug (42 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02357563Phase 4 · unknown Ulipristal Acetate Versus GnRH Analogue and Myometrial Preservation · 186 trials list this drug (42 active) | — | — | Leiomyoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02361879Phase 4 · unknown Ulipristal Acetate Versus GnRH Analogue Treatment Before Hysteroscopic Resection of Uterine Leiomyoma · 186 trials list this drug (42 active) | — | — | Leiomyoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02361905Phase 4 · unknown Ulipristal Acetate for the Preoperative Management of Hypoechoic Cellular Leiomyomas · 186 trials list this drug (42 active) | — | — | Leiomyoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00081159Phase 2 · completed Hormone Ablation Therapy, Doxorubicin, and Zoledronate With or Without Strontium 89 in Treating Patients With Androgen-Dependent Prostate Cancer and Bone Metastases · 186 trials list this drug (42 active) | — | — | Malignant Neoplasm,Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02134977completed Leuplin SR 11.25 mg Injection Kit Specified Drug-use Survey: "QOL Survey in Premenopausal Breast Cancer Patients" · 186 trials list this drug (42 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00220194Phase 4 · completed A Six-Month, Open-Label, Crossover Study Of the Maintenance Of Serum Testosterone And PSA Suppression After Switching Between Lupron 22.5 Mg And Eligard 22.5 Mg Or Zoladex 10.8 Mg And Eligard 22.5 Mg In Patients With Advanced Prostate Cancer · 186 trials list this drug (42 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00943956Phase 1 · completed Everolimus, Bicalutamide, and Leuprolide Acetate in Treating Patients Undergoing Radiation Therapy For High-Risk Locally Advanced Prostate Cancer · 186 trials list this drug (42 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02749825Phase 4 · terminated Comparison of Trelstar Versus Lupron or Zoladex in Advanced Prostate Cancer · 186 trials list this drug (42 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00903162Phase 2 · completed Extended Endocrine Therapy for Premenopausal Women With Breast Cancer · 186 trials list this drug (42 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00243646Phase 3 · terminated Implant and External Radiation for Prostate Cancer With or Without Hormonal Therapy: A Prospective Randomized Trial · 186 trials list this drug (42 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00521781Phase 2 · terminated Study of Abraxane Plus Hormonal Therapy as Initial Treatment of Unresectable or Metastatic Prostate Cancer · 186 trials list this drug (42 active) | — | — | Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02154139completed Leuprorelin Acetate SR 11.25 mg for Injection Specified Drug-use Survey "Long-term Use Survey on Premenopausal Breast Cancer Patients (96 Weeks)" · 186 trials list this drug (42 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00454571Phase 2 · completed Pazopanib Hydrochloride After Leuprolide Acetate or Goserelin Acetate in Treating Patients With Relapsed Prostate Cancer · 186 trials list this drug (42 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01511874Phase 4 · completed Efficacy and Safety Study of ELIGARD 22.5mg With Prostate Cancer · 186 trials list this drug (42 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01011751Phase 3 · completed Treatment of Hot Flushes Caused by Leuprorelin 11.25 mg in Prostate Adenocarcinoma · 186 trials list this drug (42 active) | — | — | Prostate Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00817739Phase 2 · completed Intermittent Hormonal Therapy With Leuprorelin and Flutamide in the Treatment of Stage D2 or TxNxM1b,c · 186 trials list this drug (42 active) | — | — | Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01122121Phase 3 · completed Leuprorelin Associated With Radiotherapy Versus Leuprorelin Alone in T3 - T4 or pT3 (on Biopsy) N0, M0 Prostate Cancer · 186 trials list this drug (42 active) | — | — | Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00500110Phase 2 · completed Hormonal Ablation, Imatinib Mesylate and Docetaxel for Patients With Prostate Cancer · 186 trials list this drug (42 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00004436NA · completed Randomized Study of Hormonal Regulation of Infantile Hemangioma · 186 trials list this drug (42 active) | — | — | Hemangioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00631527Phase 1 · completed Sunitinib Malate, Hormone Ablation and Radiation Therapy in Patients With Prostate Cancer · 186 trials list this drug (42 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00683917Phase 2 · terminated Pharmacokinetics, Safety and Efficacy Study of Proellex in Pre-menopausal Women With Symptomatic Uterine Fibroids · 186 trials list this drug (42 active) | — | — | Uterine Corpus Leiomyoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00949962Phase 3 · terminated Post-operative or Early Salvage XRT and ADT for High Risk PCa · 186 trials list this drug (42 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00378690Phase 3 · completed A Phase IIIb Study of Intermittent Versus Continuous Hormone Deprivation Treatment With ELIGARD · 186 trials list this drug (42 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00452556Phase 2 · unknown The ELDORADO (Eligard®, Docetaxel and Radiotherapy) Study · 186 trials list this drug (42 active) | — | — | Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00003124Phase 2 · completed Hormone Therapy Plus Radiation Therapy in Treating Patients With Prostate Cancer · 186 trials list this drug (42 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00002580Phase 3 · completed Tamoxifen, Ovarian Ablation, and/or Combination Chemotherapy in Treating Premenopausal Women With Stage I, Stage II, or Stage IIIA Invasive Breast Cancer · 186 trials list this drug (42 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00514917Phase 3 · terminated A Study of Androgen Deprivation With Leuprolide, +/- Docetaxel for Clinically Asymptomatic Prostate Cancer Participants With a Rising Prostate Specific Antigen (PSA) · 186 trials list this drug (42 active) | — | — | Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01161563Phase 4 · completed Randomized Crossover Trial to Assess the Tolerability of Gonadotropin Releasing Hormone (GnRH) Analogue Administration · 186 trials list this drug (42 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00026377Phase 1 · completed SU5416 Plus Hormone Therapy and Radiation Therapy in Treating Patients With Prostate Cancer · 186 trials list this drug (42 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00002582Phase 3 · completed Tamoxifen, Ovarian Ablation, and/or Chemotherapy in Treating Women With Stage I, Stage II, or Stage IIIA Breast Cancer · 186 trials list this drug (42 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00028769Phase 2 · completed S0032, Combination Chemotherapy Plus Hormone Therapy in Treating Patients With Metastatic Prostate Cancer · 186 trials list this drug (42 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00003517Phase 2 · withdrawn Antineoplaston Therapy in Treating Patients With Stage III or Stage IV Prostate Cancer · 186 trials list this drug (42 active) | — | — | Prostate Adenocarcinoma,Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00003394Phase 1/Phase 2 · completed Combination Chemotherapy in Treating Patients With Advanced Prostate Cancer · 186 trials list this drug (42 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00498901Phase 2 · terminated Letrozole and Goserelin or Leuprolide in Treating Premenopausal Estrogen Receptor-Positive Patients With Stage IV Breast Cancer · 186 trials list this drug (42 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00924469Phase 2 · completed A Phase 2 Study to Evaluate Safety and Efficacy of Abiraterone Acetate in Male Participants With Prostate Cancer · 186 trials list this drug (42 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00512668Phase 1 · terminated Hormone Therapy and Temsirolimus in Treating Patients With Relapsed Prostate Cancer · 186 trials list this drug (42 active) | — | — | Prostate Adenocarcinoma,Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00295750Phase 3 · completed The Efficacy and Safety of Degarelix One Month Dosing Regimens in Prostate Cancer · 186 trials list this drug (42 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00684905Phase 2 · completed Leuprolide, Bicalutamide, and Implant Radiation Therapy in Treating Patients With Locally Recurrent Prostate Cancer After External-Beam Radiation Therapy · 186 trials list this drug (42 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01081873completed Study to Document Treatment Patterns and to Evaluate Leuprolide and Alternative Therapeutic Approaches to the Treatments of Advanced Prostate Cancer · 186 trials list this drug (42 active) | — | — | Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00388804Phase 3 · terminated External Beam Radiation Therapy (EBRT) With or Without Hormonal Therapy in Prostate Cancer · 186 trials list this drug (42 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00244920Phase 2 · withdrawn Hormone Therapy With or Without Squalamine Lactate in Treating Patients Who Are Undergoing a Radical Prostatectomy for Locally Advanced Prostate Cancer · 186 trials list this drug (42 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00653757Phase 1/Phase 2 · completed Intensity-Modulated Radiation Therapy in Treating Patients With Stage I, Stage II, Stage III, or Stage IV Prostate Cancer · 186 trials list this drug (42 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01132404Phase 1/Phase 2 · terminated Study in Men With Prostate Cancer to Assess the Safety, Pharmacokinetics and Testosterone-Lowering Efficacy of TAK-448 · 186 trials list this drug (42 active) | — | — | Prostate Neoplasm,Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00805935Phase 4 · completed Menopur® Versus Follistim® in Polycystic Ovarian Syndrome (PCOS) · 186 trials list this drug (42 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00002881Phase 3 · completed Flutamide, Suramin, and Hydrocortisone in Treating Patients With Prostate Cancer · 186 trials list this drug (42 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00630799Phase 3 · terminated Efficacy and Safety Study of a New Leuprolide Acetate 17 mg Depot to Treat Prostate Cancer Patients · 186 trials list this drug (42 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00776074Phase 2 · completed A Pharmacodynamic Study of Leuprorelin Gelatin-Free Formulation in Female Subjects With Uterine Fibroids. · 186 trials list this drug (42 active) | — | — | Uterine Corpus Leiomyoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00056654NA · completed Study of a 6-Month Sustained-Release Formulation of Leuprolide Acetate in Prostate Cancer · 186 trials list this drug (42 active) | — | — | Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00128531Phase 3 · completed Leuprolide Acetate 3.75 mg Depot to Treat Prostate Cancer · 186 trials list this drug (42 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00004311Phase 2 · completed Phase II Study of the Effect of Leuprolide Acetate and Spironolactone on Insulin Resistance in Hyperandrogenic Women With Polycystic Ovarian Disease or Hyperandrogenism Insulin Resistance Acanthosis Nigricans Syndrome · 186 trials list this drug (42 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |